These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25933723)

  • 1. Application of clinical bioinformatics in lung cancer-specific biomarkers.
    Wu D; Wang X
    Cancer Metastasis Rev; 2015 Jun; 34(2):209-16. PubMed ID: 25933723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cancer secretome, current status and opportunities in the lung, breast and colorectal cancer context.
    Schaaij-Visser TB; de Wit M; Lam SW; Jiménez CR
    Biochim Biophys Acta; 2013 Nov; 1834(11):2242-58. PubMed ID: 23376433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preface on application of omics technologies in cancer biology and therapy.
    Georgakilas AG
    Cancer Lett; 2016 Nov; 382(1):A1. PubMed ID: 27765153
    [No Abstract]   [Full Text] [Related]  

  • 4. Genomics and proteomics: emerging technologies in clinical cancer research.
    Chung CH; Levy S; Chaurand P; Carbone DP
    Crit Rev Oncol Hematol; 2007 Jan; 61(1):1-25. PubMed ID: 17015021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of reverse phase protein array (RPPA)-based pathway-activation profiling in 84 non-small cell lung cancer (NSCLC) cell lines as platform for cancer proteomics and biomarker discovery.
    Ummanni R; Mannsperger HA; Sonntag J; Oswald M; Sharma AK; König R; Korf U
    Biochim Biophys Acta; 2014 May; 1844(5):950-9. PubMed ID: 24361481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical informatics: transition from data acquisition to data analysis by means of bioinformatics tools and resources.
    Mahdavi MA
    Int J Data Min Bioinform; 2010; 4(2):158-74. PubMed ID: 20423018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From Uniplex to Multiplex Molecular Profiling in Advanced Non-Small Cell Lung Carcinoma.
    Ileana EE; Wistuba II; Izzo JG
    Cancer J; 2015; 21(5):413-24. PubMed ID: 26389767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical bioinformatics.
    Chang PL
    Chang Gung Med J; 2005 Apr; 28(4):201-11. PubMed ID: 16013339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional genomics and proteomics in the clinical neurosciences: data mining and bioinformatics.
    Phan JH; Quo CF; Wang MD
    Prog Brain Res; 2006; 158():83-108. PubMed ID: 17027692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers for the lung cancer diagnosis and their advances in proteomics.
    Sung HJ; Cho JY
    BMB Rep; 2008 Sep; 41(9):615-25. PubMed ID: 18823584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OrCanome: a Comprehensive Resource for Oral Cancer.
    Bhartiya D; Kumar A; Singh H; Sharma A; Kaushik A; Kumari S; Mehrotra R
    Asian Pac J Cancer Prev; 2016; 17(3):1333-6. PubMed ID: 27039767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in molecular acute lung injury/acute respiratory distress syndrome and ventilator-induced lung injury: the role of genomics, proteomics, bioinformatics and translational biology.
    Lam E; dos Santos CC
    Curr Opin Crit Care; 2008 Feb; 14(1):3-10. PubMed ID: 18195619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical proteomics: from biomarker discovery and cell signaling profiles to individualized personal therapy.
    Calvo KR; Liotta LA; Petricoin EF
    Biosci Rep; 2005; 25(1-2):107-25. PubMed ID: 16222423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomics biomarkers for non-small cell lung cancer.
    Kisluk J; Ciborowski M; Niemira M; Kretowski A; Niklinski J
    J Pharm Biomed Anal; 2014 Dec; 101():40-9. PubMed ID: 25175018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The state of molecular biomarkers for the early detection of lung cancer.
    Hassanein M; Callison JC; Callaway-Lane C; Aldrich MC; Grogan EL; Massion PP
    Cancer Prev Res (Phila); 2012 Aug; 5(8):992-1006. PubMed ID: 22689914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Application of bioinformatics in study of Chinese medicine resources].
    Xie T; Wang S; Ma J; Guo LP
    Zhongguo Zhong Yao Za Zhi; 2012 Dec; 37(24):3684-90. PubMed ID: 23627160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translational Research and Plasma Proteomic in Cancer.
    Santini AC; Giovane G; Auletta A; Di Carlo A; Fiorelli A; Cito L; Astarita C; Giordano A; Alfano R; Feola A; Di Domenico M
    J Cell Biochem; 2016 Apr; 117(4):828-35. PubMed ID: 26479787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomics in cancer research: Are we ready for clinical practice?
    Maes E; Mertens I; Valkenborg D; Pauwels P; Rolfo C; Baggerman G
    Crit Rev Oncol Hematol; 2015 Dec; 96(3):437-48. PubMed ID: 26277237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic immune markers in non-small cell lung cancer--letter.
    Pandey JP
    Clin Cancer Res; 2011 Dec; 17(24):7835; author reply 7836. PubMed ID: 22147937
    [No Abstract]   [Full Text] [Related]  

  • 20. Can lung cancer stem cells be targeted for therapies?
    Wu X; Chen H; Wang X
    Cancer Treat Rev; 2012 Oct; 38(6):580-8. PubMed ID: 22436486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.